Search Results - "Tabor, Jennifer"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model

    Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model by Lasko, Maxwell J, Tabor-Rennie, Jennifer L, Nicolau, David P, Kuti, Joseph L

    Published in Journal of antimicrobial chemotherapy (28-10-2022)
    “…Abstract Background Trimethoprim/sulfamethoxazole has historically been the treatment of choice for infection caused by Stenotrophomonas maltophilia. This…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    In Vitro Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth

    In Vitro Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth by Lasko, Maxwell J, Gethers, Matthew L, Tabor-Rennie, Jennifer L, Nicolau, David P, Kuti, Joseph L

    Published in Antimicrobial agents and chemotherapy (15-03-2022)
    “…Trimethoprim/sulfamethoxazole (TMP/SMZ) is considered the treatment of choice for infections caused by Stenotrophomonas maltophilia, but limited…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Changing Fonts in Education: How the Benefits Vary with Ability and Dyslexia

    Changing Fonts in Education: How the Benefits Vary with Ability and Dyslexia by French, M. M. J., Blood, Arabella, Bright, N. D., Futak, Dez, Grohmann, M. J., Hasthorpe, Alex, Heritage, John, Poland, Remy L., Reece, Simon, Tabor, Jennifer

    “…Previous research has shown that presenting educational materials in slightly harder to read fonts than is typical engenders deeper processing. This leads to…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model

    In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model by Monogue, Marguerite L, Tabor-Rennie, Jennifer, Abdelraouf, Kamilia, Nicolau, David P

    Published in Antimicrobial agents and chemotherapy (01-07-2019)
    “…We describe the efficacy of human-simulated WCK 5222 (cefepime-zidebactam) exposure against multidrug-resistant (meropenem MICs 8 to >256 μg/ml) in a…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: